跳至主要内容
临床试验/NCT04200937
NCT04200937Enrolling By Invitation不适用

IT Matters: The Erectile Restoration Registry

Boston Scientific Corporation38 个研究点 分布在 3 个国家目标入组 450 人开始时间: 2021年8月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
450
试验地点
38
主要终点
Change from baseline to six months in the Erectile Function domain ofthe International Index of Erectile Function (IIEF-EF) questionnaire for Tactra

研究概览

简要总结

The objective of the It MATTERS registry is to collect Real-World Data (RWD) to monitor the safe and effective use of commercially available Boston Scientific Corporation (BSC) penile prostheses

详细描述

IT MATTERS is a prospective, multicenter, observational registry that is part of planned, active post market clinical follow-up (PMCF) activity associated with each device.

The study will include adult males who undergo penile prothesis implantation with a market approved BSC device to treat erectile dysfunction.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • ≥ 18 years of age.
  • Males who are determined to be suitable candidates and scheduled to undergo surgical implantation of a market approved BSC penile prothesis by their physician.
  • Willing and able to complete the informed consent process.
  • Willing and able to comply with the follow-up requirements.

排除标准

  • Males who are deemed by their physician as not suitable candidates for a penile prosthesis.
  • In the opinion of the investigator, it is not in best interest of the patient or the study for the patient to participate.

研究组 & 干预措施

BSC Penile Prothesis Recipients

Men for whom BSC Penile Prothesis is recommended.

干预措施: AMS Ambicor™ Inflatable Penile Prosthesis (Device)

BSC Penile Prothesis Recipients

Men for whom BSC Penile Prothesis is recommended.

干预措施: AMS 700™ Inflatable Penile Prosthesis w/Tenacio™ Pump (Device)

BSC Penile Prothesis Recipients

Men for whom BSC Penile Prothesis is recommended.

干预措施: Tactra Malleable (Device)

BSC Penile Prothesis Recipients

Men for whom BSC Penile Prothesis is recommended.

干预措施: Spectra™ Concealable Penile Prothesis (Device)

BSC Penile Prothesis Recipients

Men for whom BSC Penile Prothesis is recommended.

干预措施: AMS 700™ Inflatable Penile Prosthesis w/Momentary Squeeze (MS) Pump (Device)

结局指标

主要结局

Change from baseline to six months in the Erectile Function domain ofthe International Index of Erectile Function (IIEF-EF) questionnaire for Tactra

时间窗: Baseline to 6 months

The International Index of Erectile Function (IIEF) is a validated, widely used, multidimensional self-report instrument for the evaluation of erectile function. It consists of 15 items that assess sexual function in five domains: erectile function (Q1, 2, 3, 4, 5,15), orgasmic function (Q9,10), sexual desire (Q11,12), intercourse satisfaction (Q 6,7,8) and overall satisfaction (Q 13,14). A score of 0-5 is awarded to each of the 15 questions. The IIEF-15 total score is the sum of the ordinal responses to the 5 domains. The erectile function (EF) domain is the most sensitive domain of the IIEF. IIEF-EF score ranges from 1 to 30 and is derived by scoring 0 (poorest function) to 5 (best function) on each of six questions function (Q1, 2, 3, 4, 5, 15). There are five categories of erectile function based on EF domain score: severe (1-10), moderate (11-16), mild to moderate (17-21), mild (22-25) and no ED (26-30).

次要结局

  • Change in erectile function at post-surgery, 12 months and annually post device implantation compared to baseline, as measured by the International Index of Erectile Function Domain (IIEF).(Post-Surgery, 12 months and annually thereafter through study completion, an average of 10 years)
  • Change in depressive symptoms and overall sexual function at Post-Surgery, 6 months, 12 months and annually thereafter post device implantation compared to baseline, as measured by the PHQ-9 Depression Questionnaire and the IIEF: Total Score.(Post-Surgery, 6 months, 12 months and annually thereafter through study completion, an average of 10 years)
  • Change in quality of life at 6 months, 12 months, and 24 months post device implantation compared to baseline as measured by the WPAI:GH Questionnaire.(6 months, 12 months and 24 months)
  • Change in depressive symptoms and overall sexual function at Post-Surgery, 6 months, and 12 months post device implantation compared to baseline, as measured by the PHQ-9 Depression Questionnaire and the IIEF: Total Score.(Post-Surgery, 6 months, and 12 months)
  • Change in quality of life at 6 months, and 12 months post device implantation compared to baseline as measured by the WPAI:GH Questionnaire.(6 months, and 12 months)
  • Change in erectile function at post-surgery, and 12 months post device implantation compared to baseline, as measured by the International Index of Erectile Function Domain (IIEF).(Post-Surgery, and 12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (38)

Loading locations...

相似试验